Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7387 p157
11 February 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Sexual health clinics lack capacity to deal with increasing number of chlamydia infections

Chlamydia remained the most common sexually transmitted infection between 2000 and 2004 in the UK, with new cases per 1,000 patients attending genitourinary clinics up from 117 to 175, according to figures published by the Office for National Statistics last month. The highest rates of increase occurred in young women aged between 16 and 19 years and in men aged 20 to 24 years.

However, research published in the journal Sexually Transmitted Infections last week suggests that the sharp increase in reported Chlamydia trachomatis infections could be down to the use of more sensitive testing methods (2006;82:24). The researchers looked at more than 81,000 test results obtained in one Scottish health board between 1992 and 2003. After 1998, testing methods were changed from cultures to more sensitive nucleic acid amplification testing, the researchers explained.

The increase in positive results when the tests were switched equates to 62 per cent for women and 56 per cent for men, they said. They argue that analysis of the results shows that the increase is strongly linked to the type of test used (odds ratio 1.61, 95 per cent confidence interval 1.33–1.94; P<0.001), irrespective of the year of the test or the sex and age of the patient — both known risk factors for infection.

In the same issue (ibid, p45) it is reported that sexual health clinics will need to triple their capacity in order to meet the 48-hour access target set by the Government for 2008. Researchers reviewed demand for appointments over five days at a large sexual health clinic in Leeds that operates a 48-hour closed appointment system. They calculated that 626 appointments would have been required to meet the demand, however only 181 new appointment slots were available.

Back to Top


©The Pharmaceutical Journal